Bioequivalence Study Of Verapamil

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Healthy Volunteers

Interventions

DRUG

verapamil

240 mg extended release tablets once daily at bedtime for 28 days

DRUG

verapamil

240 mg extended release tablets once daily at bedtime for 28 days

Trial Locations (1)

Pfizer Investigational Site, New Haven